X. Jannot et al., “Autoantibodies directed against insulin receptor during the course of Castleman disease: a new case reaffirming autoimmune hypoglycemia as a relapse warning signal”, EJCRIM, vol. 12, no. 5, Apr. 2025, doi: 10.12890/2025_005355.